|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating expenses | |||||
| General and administrative | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Other (income) and expenses | |||||
| Unrealized gain | |||||
| Realized and accrued interest income | |||||
| Total other income | |||||
| Net loss | |||||
| Net loss attributable to shareholders | |||||
| Other comprehensive loss | |||||
| Foreign currency translation | |||||
| Total other comprehensive loss | |||||
| Comprehensive loss | |||||
| Loss per ADS | |||||
| Basic | |||||
| ADS | |||||
| Fully-diluted | |||||
| ADS | |||||
| Weighted average number of ADS's outstanding | |||||
| Basic | |||||
| ADS | |||||
| Fully-diluted | |||||
| ADS | |||||
Loading...